Knights Landing, CA, United States of America

Michelle M Wiest

This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignees: Children's Hospital Research Center at Oakland, Duke University, Lipomics Technologies, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle M Wiest. Retrieved from https://idiyas.com/inventor/michelle-m-wiest

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Michelle M Wiest in Cardiovascular Disease Research

Introduction

Michelle M Wiest, an accomplished inventor based in Knights Landing, California, has made significant strides in the field of cardiovascular research. With her innovative approach, she has contributed valuable insights into how lipidomics can influence the treatment of cardiovascular disorders. Her dedication to advancing medical science has led to the development of a patent that holds promise for improving patient outcomes.

Latest Patents

Michelle Wiest is recognized for her patent titled "Lipidomic approaches to determining drug response phenotypes in cardiovascular disease." This invention focuses on utilizing lipidomics to enhance the effectiveness of statin treatments. The patent describes a method for correlating lipid profiles from samples taken from mammalian subjects both before and after commencing statin treatment. By analyzing these lipid profiles, the invention aims to identify positive or negative responses to the treatment, offering a potential pathway to tailored treatments for individuals with cardiovascular disorders.

Career Highlights

Throughout her career, Michelle has worked at prominent institutions, including the Children's Hospital & Research Center at Oakland and Duke University. Her roles in these organizations have facilitated her engagement in groundbreaking research, leveraging her expertise in lipidomics and cardiovascular health to make oral advancements in medical practices.

Collaborations

Michelle has collaborated with notable professionals in her field, including Rima Kaddurah-Daouk and Steven M Watkins. These collaborations have enhanced her research, fostering an environment of shared knowledge and innovation.

Conclusion

Michelle M Wiest exemplifies the spirit of innovation through her work in lipidomics and cardiovascular disease. With her patent, she has paved the way for more effective and personalized treatments for cardiovascular disorders. Her contributions demonstrate the critical importance of ongoing research and collaboration in advancing medical science, ultimately aiming to improve patient care and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…